Evidence map›Paper›PMID 31409279›Full record

ArticleBMC medical genetics2019

Novel reference genes in colorectal cancer identify a distinct subset of high stage tumors and their associated histologically normal colonic tissues.

Lai Xu, Helen Luo, Rong Wang, Wells W Wu, Je-Nie Phue, Rong-Fong Shen, Hartmut Juhl, Leihong Wu, Wei-Lun Alterovitz, Vahan Simonyan and 2 more

Open access · goldAbstract read
In one paragraph

Article in BMC medical genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Lai XuOBP/DBRR-III, CDER, FDA, Silver Spring, MD, 20993, USA. lai.xu@fda.hhs.gov.ORCID 0000-0002-3546-0563
Helen LuoOBP/DBRR-III, CDER, FDA, Silver Spring, MD, 20993, USA.
Rong WangOBP/DBRR-III, CDER, FDA, Silver Spring, MD, 20993, USA.
Wells W WuFacility for Biotechnology Resources CBER, FDA, Silver Spring, MD, 20993, USA.
Je-Nie PhueFacility for Biotechnology Resources CBER, FDA, Silver Spring, MD, 20993, USA.
Rong-Fong ShenFacility for Biotechnology Resources CBER, FDA, Silver Spring, MD, 20993, USA.
Hartmut JuhlIndivumed GMBH, 20251, Hamburg, Germany.
Leihong WuOCS/NCTR/DBB, FDA, 3900 NCTR Road, Jefferson, AR, 72079, USA.
Wei-Lun AlterovitzOBE/HIVE CBER, FDA, Silver Spring, MD, 20993, USA.
Vahan SimonyanOBE/HIVE CBER, FDA, Silver Spring, MD, 20993, USA.
Lorraine PelosofOffice of Hematology and Oncology Products CDER, FDA, Silver Spring, MD, 20993, USA.
Amy S RosenbergOBP/DBRR-III, CDER, FDA, Silver Spring, MD, 20993, USA.
Center for Devices and Radiological Health · USNational Center for Toxicological Research · USUnited States Food and Drug Administration · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundReference genes are often interchangeably called housekeeping genes due to 1) the essential cellular functions their proteins provide and 2) their constitutive expression across a range of normal and pathophysiological conditions. However, given the proliferative drive of malignant cells, many reference genes such as beta-actin (ACTB) and glyceraldehyde-3-phosphate-dehydrogenase (GAPDH) which play critical roles in cell membrane organization and glycolysis, may be dysregulated in tumors versus their corresponding normal controls

methodsBecause Next Generation Sequencing (NGS) technology has several advantages over hybridization-based technologies, such as independent detection and quantitation of transcription levels, greater sensitivity, and increased dynamic range, we evaluated colorectal cancers (CRC) and their histologically normal tissue counterparts by NGS to evaluate the expression of 21 "classical" reference genes used as normalization standards for PCR based methods. Seventy-nine paired tissue samples of CRC and their patient matched healthy colonic tissues were subjected to NGS analysis of their mRNAs.

resultsWe affirmed that 17 out of 21 classical reference genes had upregulated expression in tumors compared to normal colonic epithelial tissue and dramatically so in some cases. Indeed, tumors were distinguished from normal controls in both unsupervised hierarchical clustering analyses (HCA) and principal component analyses (PCA). We then identified 42 novel potential reference genes with minimal coefficients of variation (CV) across 79 CRC tumor pairs. Though largely consistently expressed across tumors and normal control tissues, a subset of high stage tumors (HSTs) as well as some normal tissue samples (HSNs) located adjacent to these HSTs demonstrated dysregulated expression, thus identifying a subset of tumors with a potentially distinct and aggressive biological profile.

conclusionWhile classical CRC reference genes were found to be differentially expressed between tumors and normal controls, novel reference genes, identified via NGS, were more consistently expressed across malignant and normal colonic tissues. Nonetheless, a subset of HST had profound dysregulation of such genes as did many of the histologically normal tissues adjacent to such HSTs, indicating that the HSTs so distinguished may have unique biological properties and that their histologically normal tissues likely harbor a small population of microscopically undetected but metabolically active tumors.

Indexed as

Genetic Association StudiesActinsBiomarkers, TumorColonColorectal NeoplasmsFemaleGene Expression ProfilingGene Expression Regulation, NeoplasticGenes, EssentialGenetic Predisposition to DiseaseGlyceraldehyde-3-Phosphate DehydrogenasesHigh-Throughput Nucleotide SequencingHumansMaleRNA, MessengerSequence Analysis, RNAActinsBiomarkers, TumorGlyceraldehyde-3-Phosphate DehydrogenasesRNA, MessengerAnd molecular abnormalities in tumor adjacent tissuesColorectal reference genesHigh stage tumors

Identifiers

PMID31409279
PMCPMC6693228
OpenAlexW2968762247

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.